share_log

Matinas BioPharma | 8-K: Matinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights

SEC ·  May 12, 2022 18:30
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.